Yersal O - Search Results

1

Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.

Omar M, Tanriverdi O, Cokmert S, Oktay E, Yersal O, Pilancı KN, Menekse S, Kocar M, Sen CA, Ordu C, Goksel G, Meydan N, Barutca S; Turkish Descriptive Oncological Researches Group. Omar M, et al. Among authors: yersal o. Clin Respir J. 2018 Mar;12(3):922-929. doi: 10.1111/crj.12605. Epub 2017 Jan 6. Clin Respir J. 2018. PMID: 28026133

2

Etoposide hypersensitivity.

Yersal O, Barutca S, Meydan N. Yersal O, et al. J BUON. 2013 Apr-Jun;18(2):547-8. J BUON. 2013. PMID: 23818380 No abstract available.

3

Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain Irradiation.

Oktay E, Yersal O, Meydan N, Sağıroğlu M, Uyanık O, Barutca S. Oktay E, et al. Among authors: yersal o. Case Rep Oncol Med. 2013;2013:234391. doi: 10.1155/2013/234391. Epub 2013 Sep 26. Case Rep Oncol Med. 2013. PMID: 24191208 Free PMC article.

4

Biological subtypes of breast cancer: Prognostic and therapeutic implications.

Yersal O, Barutca S. Yersal O, et al. World J Clin Oncol. 2014 Aug 10;5(3):412-24. doi: 10.5306/wjco.v5.i3.412. World J Clin Oncol. 2014. PMID: 25114856 Free PMC article. Review.

5

Blastocystis subtypes in cancer patients: Analysis of possible risk factors and clinical characteristics.

Yersal O, Malatyali E, Ertabaklar H, Oktay E, Barutca S, Ertug S. Yersal O, et al. Parasitol Int. 2016 Dec;65(6 Pt B):792-796. doi: 10.1016/j.parint.2016.02.010. Epub 2016 Feb 21. Parasitol Int. 2016. PMID: 26905740

6

Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens.

Yersal Ö, Eryilmaz U, Akdam H, Meydan N, Barutca S. Yersal Ö, et al. Cardiol Res Pract. 2018 May 2;2018:5352914. doi: 10.1155/2018/5352914. eCollection 2018. Cardiol Res Pract. 2018. PMID: 29854434 Free PMC article.

7

Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioblastoma.

Yersal Ö, Odabaşi E, Özdemir Ö, Kemal Y. Yersal Ö, et al. Mol Clin Oncol. 2018 Oct;9(4):453-458. doi: 10.3892/mco.2018.1695. Epub 2018 Aug 9. Mol Clin Oncol. 2018. PMID: 30233797 Free PMC article.

8

Molecular subtypes are prognostic for N3 breast cancer patients in the modern therapeutic era.

Yersal Ö, Kaplan MA, Işikdoğan A, Özdemir N, Aliustaoğlu M, Barutca S, Erdoğdu Hİ, Meydan N. Yersal Ö, et al. Mol Clin Oncol. 2019 Jan;10(1):180-184. doi: 10.3892/mco.2018.1771. Epub 2018 Nov 19. Mol Clin Oncol. 2019. PMID: 30655995 Free PMC article.

9

Prognostic significance of novel inflammatory markers in extensive-stage small-cell lung cancer.

Yilmaz H, Yersal Ö. Yilmaz H, et al. Among authors: yersal o. J Cancer Res Ther. 2022 Apr-Jun;18(3):691-696. doi: 10.4103/jcrt.jcrt_1937_21. J Cancer Res Ther. 2022. PMID: 35900541 Free article.

10

The prognostic importance of glucose-to-lymphocyte ratio and uric acid in metastatic breast cancer patients treated with Cdk 4/6 inhibitors.

Yilmaz H, Nigdelioglu B, Aytac A, Turan M, Oktay E, Yersal O, Barutca S. Yilmaz H, et al. Among authors: yersal o. Future Oncol. 2022 Sep;18(27):3043-3053. doi: 10.2217/fon-2022-0464. Epub 2022 Sep 5. Future Oncol. 2022. PMID: 36062468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters